Cite This Page
Bibliographic details for Lymphoblastic predominance associated with blastic cycle in youngsters along with longterm myeloid leukaemia helped by imatinib An investigation in the ICMLPed Examine
- Page name: Lymphoblastic predominance associated with blastic cycle in youngsters along with longterm myeloid leukaemia helped by imatinib An investigation in the ICMLPed Examine
- Author: OPENN - EUROPESE OMROEP - OFFICIAL PUBLIC EUROPEAN NETHERLANDS NETWORK contributors
- Publisher: OPENN - EUROPESE OMROEP - OFFICIAL PUBLIC EUROPEAN NETHERLANDS NETWORK, .
- Date of last revision: 17 January 2024 07:13 UTC
- Date retrieved: 13 May 2024 11:26 UTC
- Permanent URL: https://news.npo.digital/index.php?title=Lymphoblastic_predominance_associated_with_blastic_cycle_in_youngsters_along_with_longterm_myeloid_leukaemia_helped_by_imatinib_An_investigation_in_the_ICMLPed_Examine&oldid=548508
- Page Version ID: 548508
Citation styles for Lymphoblastic predominance associated with blastic cycle in youngsters along with longterm myeloid leukaemia helped by imatinib An investigation in the ICMLPed Examine
APA style
Lymphoblastic predominance associated with blastic cycle in youngsters along with longterm myeloid leukaemia helped by imatinib An investigation in the ICMLPed Examine. (2024, January 17). OPENN - EUROPESE OMROEP - OFFICIAL PUBLIC EUROPEAN NETHERLANDS NETWORK, . Retrieved 11:26, May 13, 2024 from https://news.npo.digital/index.php?title=Lymphoblastic_predominance_associated_with_blastic_cycle_in_youngsters_along_with_longterm_myeloid_leukaemia_helped_by_imatinib_An_investigation_in_the_ICMLPed_Examine&oldid=548508.
MLA style
"Lymphoblastic predominance associated with blastic cycle in youngsters along with longterm myeloid leukaemia helped by imatinib An investigation in the ICMLPed Examine." OPENN - EUROPESE OMROEP - OFFICIAL PUBLIC EUROPEAN NETHERLANDS NETWORK, . 17 Jan 2024, 07:13 UTC. 13 May 2024, 11:26 <https://news.npo.digital/index.php?title=Lymphoblastic_predominance_associated_with_blastic_cycle_in_youngsters_along_with_longterm_myeloid_leukaemia_helped_by_imatinib_An_investigation_in_the_ICMLPed_Examine&oldid=548508>.
MHRA style
OPENN - EUROPESE OMROEP - OFFICIAL PUBLIC EUROPEAN NETHERLANDS NETWORK contributors, 'Lymphoblastic predominance associated with blastic cycle in youngsters along with longterm myeloid leukaemia helped by imatinib An investigation in the ICMLPed Examine', OPENN - EUROPESE OMROEP - OFFICIAL PUBLIC EUROPEAN NETHERLANDS NETWORK, , 17 January 2024, 07:13 UTC, <https://news.npo.digital/index.php?title=Lymphoblastic_predominance_associated_with_blastic_cycle_in_youngsters_along_with_longterm_myeloid_leukaemia_helped_by_imatinib_An_investigation_in_the_ICMLPed_Examine&oldid=548508> [accessed 13 May 2024]
Chicago style
OPENN - EUROPESE OMROEP - OFFICIAL PUBLIC EUROPEAN NETHERLANDS NETWORK contributors, "Lymphoblastic predominance associated with blastic cycle in youngsters along with longterm myeloid leukaemia helped by imatinib An investigation in the ICMLPed Examine," OPENN - EUROPESE OMROEP - OFFICIAL PUBLIC EUROPEAN NETHERLANDS NETWORK, , https://news.npo.digital/index.php?title=Lymphoblastic_predominance_associated_with_blastic_cycle_in_youngsters_along_with_longterm_myeloid_leukaemia_helped_by_imatinib_An_investigation_in_the_ICMLPed_Examine&oldid=548508 (accessed May 13, 2024).
CBE/CSE style
OPENN - EUROPESE OMROEP - OFFICIAL PUBLIC EUROPEAN NETHERLANDS NETWORK contributors. Lymphoblastic predominance associated with blastic cycle in youngsters along with longterm myeloid leukaemia helped by imatinib An investigation in the ICMLPed Examine [Internet]. OPENN - EUROPESE OMROEP - OFFICIAL PUBLIC EUROPEAN NETHERLANDS NETWORK, ; 2024 Jan 17, 07:13 UTC [cited 2024 May 13]. Available from: https://news.npo.digital/index.php?title=Lymphoblastic_predominance_associated_with_blastic_cycle_in_youngsters_along_with_longterm_myeloid_leukaemia_helped_by_imatinib_An_investigation_in_the_ICMLPed_Examine&oldid=548508.
Bluebook style
Lymphoblastic predominance associated with blastic cycle in youngsters along with longterm myeloid leukaemia helped by imatinib An investigation in the ICMLPed Examine, https://news.npo.digital/index.php?title=Lymphoblastic_predominance_associated_with_blastic_cycle_in_youngsters_along_with_longterm_myeloid_leukaemia_helped_by_imatinib_An_investigation_in_the_ICMLPed_Examine&oldid=548508 (last visited May 13, 2024).
BibTeX entry
@misc{ wiki:xxx, author = "OPENN - EUROPESE OMROEP - OFFICIAL PUBLIC EUROPEAN NETHERLANDS NETWORK", title = "Lymphoblastic predominance associated with blastic cycle in youngsters along with longterm myeloid leukaemia helped by imatinib An investigation in the ICMLPed Examine --- OPENN - EUROPESE OMROEP - OFFICIAL PUBLIC EUROPEAN NETHERLANDS NETWORK{,} ", year = "2024", url = "https://news.npo.digital/index.php?title=Lymphoblastic_predominance_associated_with_blastic_cycle_in_youngsters_along_with_longterm_myeloid_leukaemia_helped_by_imatinib_An_investigation_in_the_ICMLPed_Examine&oldid=548508", note = "[Online; accessed 13-May-2024]" }
When using the LaTeX package url (\usepackage{url}
somewhere in the preamble) which tends to give much more nicely formatted web addresses, the following may be preferred:
@misc{ wiki:xxx, author = "OPENN - EUROPESE OMROEP - OFFICIAL PUBLIC EUROPEAN NETHERLANDS NETWORK", title = "Lymphoblastic predominance associated with blastic cycle in youngsters along with longterm myeloid leukaemia helped by imatinib An investigation in the ICMLPed Examine --- OPENN - EUROPESE OMROEP - OFFICIAL PUBLIC EUROPEAN NETHERLANDS NETWORK{,} ", year = "2024", url = "\url{https://news.npo.digital/index.php?title=Lymphoblastic_predominance_associated_with_blastic_cycle_in_youngsters_along_with_longterm_myeloid_leukaemia_helped_by_imatinib_An_investigation_in_the_ICMLPed_Examine&oldid=548508}", note = "[Online; accessed 13-May-2024]" }